School of Medicine, Keele University, Keele, UK.
Haywood Academic Rheumatology Centre, Stoke-on-Trent, Staffordshire, UK.
Osteoporos Int. 2022 Nov;33(11):2245-2257. doi: 10.1007/s00198-022-06453-4. Epub 2022 Jun 11.
Systematic reviews that examine effectiveness of interventions to improve medicines optimisation do not explain how or why they work. This realist review identified that interventions which effectively optimise medicines use in osteoporosis include opportunities to address patients' perceptions of illness and treatment and/or support primary care clinician decision making.
In people with osteoporosis, adherence to medicines is poorer than other diseases and patients report follow-up is lacking, and multiple unmet information needs. We conducted a rapid realist review to understand what contextual conditions and mechanisms enable interventions to support osteoporosis medication optimisation.
A primary search identified observational or interventional studies which aimed to improve medicines adherence or optimisation; a supplementary second search identified research of any design to gain additional insights on emerging findings. Extracted data was interrogated for patterns of context-mechanism-outcome configurations, further discussed in team meetings, informed by background literature and the Practicalities and Perception Approach as an underpinning conceptual framework.
We identified 5 contextual timepoints for the person with osteoporosis (identifying a problem; starting medicine; continuing medicine) and the practitioner and healthcare system (making a diagnosis and giving a treatment recommendation; reviewing medicine). Interventions which support patient-informed decision making appear to influence long-term commitment to treatment. Supporting patients' practical ability to adhere (e.g. by lowering treatment burden and issuing reminders) only appears to be helpful, when combined with other approaches to address patient beliefs and concerns. However, few studies explicitly addressed patients' perceptions of illness and treatment. Supporting primary care clinician decision making and integration of primary and secondary care services also appears to be important, in improving rates of treatment initiation and adherence.
We identified a need for further research to identify a sustainable, integrated, patient-centred, and cost- and clinically effective model of long-term care for people with osteoporosis.
系统评价检查改善药物优化干预措施的效果,但并未解释其作用机制。本真实主义综述旨在确定,能有效优化骨质疏松症药物使用的干预措施包括有机会解决患者对疾病和治疗的看法,以及支持初级保健临床医生的决策。
初步检索确定了旨在提高药物依从性或优化药物使用的观察性或干预性研究;补充的二次检索确定了任何设计的研究,以获得对新兴发现的更多见解。提取的数据被质疑了模式的上下文机制结果配置,并在团队会议中进一步讨论,由背景文献和实用性和感知方法提供信息作为一个基础的概念框架。
我们确定了骨质疏松症患者的 5 个时间点(发现问题;开始用药;继续用药)和从业者和医疗保健系统(做出诊断和提出治疗建议;审查药物)。支持患者知情决策的干预措施似乎会影响长期的治疗承诺。支持患者的实际服药依从能力(例如,降低治疗负担和发出提醒)似乎只有在与其他解决患者信念和顾虑的方法相结合时才会有所帮助。然而,很少有研究明确解决患者对疾病和治疗的看法。支持初级保健临床医生的决策和整合初级和二级保健服务也似乎很重要,以提高治疗开始和依从率。
我们确定需要进一步研究,以确定一种可持续、综合、以患者为中心、具有成本效益和临床效果的长期护理模式,为骨质疏松症患者提供服务。